CD19 and neoplasm: Introduction of GOF mutations in PIK3CD and PIK3R1 into T cells expressing either tumor-specific T cell receptors or various generations of CD19-directed CAR-T cells enhanced antigen-specific signaling, cytokine production, and tumor cell killing.